posted on 2021-03-05, 22:17authored byAyush Midha, Hui Pan, Cristian Abarca, Joshua Andle, Priscila Carapeto, Susan Bonner-Weir, Cristina Aguayo-Mazzucato
The aging of pancreatic β-cells may undermine their
ability to compensate for insulin resistance, leading to the development of
type 2 diabetes (T2D). Aging β-cells acquire markers of cellular senescence and
develop a senescence-associated secretory phenotype (SASP) that can lead to
senescence and dysfunction of neighboring cells through paracrine actions,
contributing to b-cell failure. Herein, we defined the β-cell SASP
signature based on unbiased proteomic analysis of conditioned media of cells
obtained from mouse and human senescent β-cells and a chemically-induced mouse
model of DNA damage capable of inducing SASP. These experiments revealed that the
β-cell SASP is enriched for factors associated with inflammation, cellular
stress response, and extracellular matrix remodeling across species. Multiple
SASP factors were transcriptionally upregulated in models of β-cell senescence,
aging, insulin resistance and T2D.
Single-cell transcriptomic analysis of islets from an in vivo
mouse model of reversible insulin resistance indicated unique and partly
reversible changes in β-cell subpopulations associated with senescence.
Collectively, these results demonstrate the unique secretory profile of
senescent b-cells and its potential implication in health and disease.
Funding
This study was supported by Institutional Startup Funds to C.A.M. (Joslin Diabetes Center) and NIH grants P30 DK036836 Joslin Diabetes Research Center (Cores; P&F to C.A.M.) and DK110390 (to S.B-W), and Thomas J. Beatson Jr. Foundation Grant #2020-010 (CAM).